Literature DB >> 28398003

Midkine in the mouse ventral tegmental area limits ethanol intake and Ccl2 gene expression.

H Chen1, D He1, A W Lasek1.   

Abstract

Midkine (MDK) is a cytokine and neurotrophic factor that is more highly expressed in the brains of alcoholics and in mice predisposed to drink large amounts of ethanol, suggesting that MDK may regulate ethanol consumption. Here we measured ethanol consumption in male and female Mdk knockout (-/-) mice using the two-bottle choice and the drinking in the dark (DID) tests. We found that Mdk -/- mice consumed significantly more ethanol than wild-type controls in both tests. To determine if MDK acts in the ventral tegmental area (VTA) to regulate ethanol consumption, we delivered lentivirus expressing a Mdk shRNA into the VTA of male C57BL/6J mice to locally knockdown Mdk and performed the DID test. Mice expressing a Mdk shRNA in the VTA consumed more ethanol than mice expressing a control non-targeting shRNA, demonstrating that the VTA is one site in the brain through which MDK acts to regulate ethanol consumption. Since MDK also controls the expression of inflammatory cytokines in other organs, we examined gene expression of interleukin-1 beta (Il1b), tumor necrosis factor alpha (Tnfα) and the chemokine (C-C motif) ligand 2 (Ccl2) in the VTA of Mdk -/- mice and in mice expressing Mdk shRNA in the VTA. Expression of Ccl2 was elevated in the VTA of Mdk -/- mice and in mice expressing Mdk shRNA in the VTA. These results demonstrate that MDK functions in the VTA to limit ethanol consumption and levels of CCL2, a chemokine known to increase ethanol consumption.
© 2017 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  Addiction; Ccl2; Il1b; Mdk; alcohol; chemokine; cytokine; dopamine; innate immune; ventral tegmental area

Mesh:

Substances:

Year:  2017        PMID: 28398003      PMCID: PMC5595638          DOI: 10.1111/gbb.12384

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  46 in total

1.  Chronic smoking and alcoholism change expression of selective genes in the human prefrontal cortex.

Authors:  Traute Flatscher-Bader; Peter A Wilce
Journal:  Alcohol Clin Exp Res       Date:  2006-05       Impact factor: 3.455

2.  Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area.

Authors:  John W Dutton; Hu Chen; Chang You; Mark S Brodie; Amy W Lasek
Journal:  Addict Biol       Date:  2016-01-11       Impact factor: 4.280

3.  Genetic inactivation of midkine modulates behavioural responses to ethanol possibly by enhancing GABA(A) receptor sensitivity to GABA(A) acting drugs.

Authors:  Marta Vicente-Rodríguez; Carmen Pérez-García; María Haro; María P Ramos; Gonzalo Herradón
Journal:  Behav Brain Res       Date:  2014-08-19       Impact factor: 3.332

4.  Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour.

Authors:  E Nakamura; K Kadomatsu; S Yuasa; H Muramatsu; T Mamiya; T Nabeshima; Q W Fan; K Ishiguro; T Igakura; S Matsubara; T Kaname; M Horiba; H Saito; T Muramatsu
Journal:  Genes Cells       Date:  1998-12       Impact factor: 1.891

5.  Chronic Intracerebroventricular Infusion of Monocyte Chemoattractant Protein-1 Leads to a Persistent Increase in Sweetened Ethanol Consumption During Operant Self-Administration But Does Not Influence Sucrose Consumption in Long-Evans Rats.

Authors:  John P Valenta; Rueben A Gonzales
Journal:  Alcohol Clin Exp Res       Date:  2015-12-19       Impact factor: 3.455

6.  Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease.

Authors:  Rui D S Prediger; Argelia E Rojas-Mayorquin; Aderbal S Aguiar; Caroline Chevarin; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Elaine Del Bel; Hisako Muramatsu; José Courty; Rita Raisman-Vozari
Journal:  J Neural Transm (Vienna)       Date:  2011-02-08       Impact factor: 3.575

7.  Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release.

Authors:  A Guyon; D Skrzydelski; I De Giry; C Rovère; G Conductier; J M Trocello; V Daugé; P Kitabgi; W Rostène; J L Nahon; S Mélik Parsadaniantz
Journal:  Neuroscience       Date:  2009-05-27       Impact factor: 3.590

8.  Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice.

Authors:  Cynthia J M Kane; Kevin D Phelan; James C Douglas; Gail Wagoner; Jennifer W Johnson; Jihong Xu; Patrick S Phelan; Paul D Drew
Journal:  Alcohol Clin Exp Res       Date:  2013-08-22       Impact factor: 3.455

9.  Midkine, a novel neurotrophic factor, promotes survival of mesencephalic neurons in culture.

Authors:  S Kikuchi; H Muramatsu; T Muramatsu; S U Kim
Journal:  Neurosci Lett       Date:  1993-09-17       Impact factor: 3.046

10.  Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration.

Authors:  Daniel García-Pérez; María Luisa Laorden; María Victoria Milanés
Journal:  Int J Neuropsychopharmacol       Date:  2015-07-11       Impact factor: 5.176

View more
  9 in total

1.  Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Authors:  Miryam Pastor; Rosalía Fernández-Calle; Bruno Di Geronimo; Marta Vicente-Rodríguez; José María Zapico; Esther Gramage; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Leonor Puchades-Carrasco; Antonio Pineda-Lucena; Beatriz de Pascual-Teresa; Gonzalo Herradón; Ana Ramos
Journal:  Eur J Med Chem       Date:  2017-11-28       Impact factor: 6.514

2.  Altered hippocampal synaptic function in transgenic mice with increased astrocyte expression of CCL2 after withdrawal from chronic alcohol.

Authors:  Jennifer G Bray; Kenneth C Reyes; Amanda J Roberts; Donna L Gruol
Journal:  Neuropharmacology       Date:  2018-02-27       Impact factor: 5.250

Review 3.  Alcohol and the brain: from genes to circuits.

Authors:  Gabor Egervari; Cody A Siciliano; Ellanor L Whiteley; Dorit Ron
Journal:  Trends Neurosci       Date:  2021-10-23       Impact factor: 13.837

Review 4.  Molecular tools to elucidate factors regulating alcohol use.

Authors:  Marian L Logrip
Journal:  Alcohol       Date:  2018-03-20       Impact factor: 2.405

5.  Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Miryam Pastor; Esther Gramage; Bruno Di Geronimo; José María Zapico; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Beatriz de Pascual-Teresa; Ana Ramos; Gonzalo Herradón
Journal:  Neuropharmacology       Date:  2018-05-09       Impact factor: 5.250

Review 6.  Neuroimmune signaling in alcohol use disorder.

Authors:  Emma K Erickson; Emily K Grantham; Anna S Warden; R A Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-12-24       Impact factor: 3.533

7.  Binge-Like Ethanol Drinking Increases Otx2, Wnt1, and Mdk Gene Expression in the Ventral Tegmental Area of Adult Mice.

Authors:  Cassandre Coles; Amy W Lasek
Journal:  Neurosci Insights       Date:  2021-04-16

Review 8.  Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder.

Authors:  Kana Hamada; Amy W Lasek
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

9.  Genetic variations in chromodomain helicase DNA-binding protein 5, gene-environment interactions and risk of sporadic Alzheimer's disease in Chinese population.

Authors:  Xiao Zhu; Haibing Yu; Qin Xiao; Jianhao Ke; Hongmei Li; Zhihong Chen; Hongrong Ding; Shuilong Leng; Yongmei Huang; Jingting Zhan; Jinli Lei; Wenguo Fan; Hui Luo
Journal:  Oncotarget       Date:  2018-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.